Previous 10 | Next 10 |
DELRAY BEACH, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact Biosciences Corp. Jonathan ...
GLEN ALLEN, Va., March 07, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced that it has retired the last of its outstanding convertible notes. Each note was exchanged for shares of ...
GLEN ALLEN, Va., March 06, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced it had placed an initial purchase order with Ceed2Med, LLC. This first order consists of over 60 SK...
GLEN ALLEN, Va., Feb. 25, 2019 (GLOBE NEWSWIRE) -- This release corrects and replaces the version issued this morning at 6:30 AM ET. The complete and corrected release follows: Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in hemp-derived, cannabidiol (CBD) pro...
GLEN ALLEN, Va., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in hemp-derived, cannabidiol (CBD) products and point of care diagnostics, launched its first product and is pleased to announce the company has received its first pu...
GLEN ALLEN, Va., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products and point of care diagnostics, announced the Company will attend the 15 th Annual PDS Super Conference in Orlando Florida...
GLEN ALLEN, VA / ACCESSWIRE / February 13, 2019 / Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products and point of care diagnostics, is pleased to announce the appointment of John Price to the Board of Directors and Chairman of ...
Former Scythian Biosciences Founder and CEO Assumes Newly Created Position GLEN ALLEN, VA / ACCESSWIRE / February 12, 2019 / Exactus Inc. (OTCQB: EXDI) a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products and point of care diagnostics, is pleased to a...
GLENN ALLEN, VA / ACCESSWIRE / February 7, 2019 / Exactus Inc. (OTCQB: EXDI) Dear Fellow Shareholders: Over the last several months the Exactus team and its advisors have been evaluating numerous opportunities and relationships to increase shareholder value. We are pleased to have identi...
Simplifies Capital Structure as it Positions for Growth GLENN ALLEN, VA / ACCESSWIRE / January 30, 2019 / Exactus Inc. (OTCQB: EXDI) a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products and point of care diagnostics, is pleased to announce that it ha...
News, Short Squeeze, Breakout and More Instantly...
Panacea Life Sciences' premium CBD products first entered Denver International Airport in May 2021, taking advantage of the near record numbers of passenger traffic GOLDEN, CO / ACCESSWIRE / October 29, 2021 / Exactus, Inc. (OTCQB:EXDI), soon to be Panacea Life Sciences, Inc. (OTCQB:PLS...
Made possible by a $1.5 million gift from CSU alumna and Panacea Life Sciences CEO, Leslie Buttorff, the center boasts state-of-the-art chemical separation and analysis instrumentation that will enable foundational research in the chemistry of cannabinoids GOLDEN, CO / ACCESSWIRE / Octob...
Hemp CBD company Exactus, Inc. (OTCQB:EXDI) acquired Panacea Life Sciences, Inc. , but the amount of the transaction was not disclosed. Panacea Life Sciences is a woman-owned and woman-led company, dedicated to developing and producing legal, hemp-derived cannabinoid products ...